Detalhe da pesquisa
1.
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering.
Bioconjug Chem
; 32(2): 301-310, 2021 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476135
2.
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.
J Immunother Cancer
; 10(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428705